DeepMirror

DeepMirror makes AI powered drug discovery as easy as using a spreadsheet through cloud based software for Biopharma.

DeepMirror is on a mission to make AI powered drug design as simple as using a spreadsheet and empower every biopharma team to find better drugs faster. Ultimately, advancing the century of biology and elevating health for all. AI can now accelerate preclinical drug discovery by 2x. But less than 10% of all biopharma teams have adopted AI due to limitations in skills and trust. DeepMirror's software helps teams deploy AI within minutes and can be used by everyone, empowering companies in their journey from discovery to clinic in a seamless user experience. Founded in 2019, DeepMirror is now used by academic institutions, biotech, and pharma businesses across the globe.

• Small molecules
• Musculoskeletal Disorders
• Immunology/inflammation
• Engineered Biology
• Pain
• Diabetes
• Neurology
• Platform Technology
• Autoimmune diseases
• Generics
• Dermatology
• Oncology
• Ear
• Nose and Throat
• Central Nervous System
• Dementia
• Metabolic Disorders
• Cardiovascular System